©The Author(s) 2025.
World J Hepatol. Jun 27, 2025; 17(6): 104693
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104693
Published online Jun 27, 2025. doi: 10.4254/wjh.v17.i6.104693
Table 2 Correlation analysis between ultrasound attenuation parameter and other parameters
| r value | P value | |
| Age | -0.331 | < 0.001 |
| Diabetes duration | -0.135 | 0.05 |
| BMI | 0.685 | < 0.001 |
| WC | 0.513 | < 0.001 |
| SBP | 0.039 | 0.573 |
| DBP | 0.203 | 0.003 |
| ALT | 0.205 | 0.003 |
| AST | 0.082 | 0.232 |
| SUA | 0.273 | < 0.001 |
| Scr | 0.012 | 0.857 |
| eGFR | 0.046 | 0.505 |
| UACR | 0.031 | 0.649 |
| TC | 0.088 | 0.202 |
| TG | 0.27 | < 0.001 |
| HDL | -0.249 | < 0.001 |
| LDL | 0.127 | 0.066 |
| GLU0 min | 0.067 | 0.329 |
| GLU120 min | -0.055 | 0.43 |
| AUCGLU 0-180 min | -0.027 | 0.698 |
| HBA1c | -0.068 | 0.328 |
| INS0 min1 | 0.361 | < 0.001 |
| INS120 min1 | 0.277 | < 0.001 |
| AUCINS 0-180 min1 | 0.289 | < 0.001 |
| HOMA-IR1 | 0.363 | < 0.001 |
| CP0 min | 0.406 | < 0.001 |
| CP120 min | 0.256 | < 0.001 |
| AUCCP 0-180 min | 0.289 | < 0.001 |
| GCG0 min1 | 0.336 | < 0.001 |
| GCGpeak1 | 0.353 | < 0.001 |
| AUCGCG 0-180 min1 | 0.353 | < 0.001 |
| LSM | 0.417 | < 0.001 |
| APRI1 | 0.102 | 0.137 |
| GPR1 | 0.202 | 0.003 |
| FIB41 | -0.262 | < 0.001 |
| PBF | 0.423 | < 0.001 |
| BMR | 0.474 | < 0.001 |
| VFA | 0.53 | < 0.001 |
| FFMI | 0.509 | < 0.001 |
| FMI | 0.536 | < 0.001 |
| SMI | 0.476 | < 0.001 |
- Citation: Sun Y, Huang P, Zhao XQ, Tang ZQ, Xu TT, Wang XW, Qi ZX, Lin WR, Li MY, Gu YJ. Relationship between glucagon and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus. World J Hepatol 2025; 17(6): 104693
- URL: https://www.wjgnet.com/1948-5182/full/v17/i6/104693.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i6.104693